본문 바로가기
bar_progress

Text Size

Close

HLB Life Science Decides to Absorb Subsidiary Aim Through Merger

[Asia Economy Reporter Myung-Hwan Lee] HLB Life Science announced on the 18th that it has decided to absorb and merge its subsidiary Aim to enhance shareholder value through increased management efficiency and the creation of financial synergies.


The merger ratio is 1 to 0, and the scheduled merger date is October 1.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top